Alyeska Investment Group’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Alyeska Investment Group’s Portfolio MDVL Stock Details MDVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-87,618	Closed	-$393K	–	661
2023 Q4	$393K	Sell	87,618 -28,682	-25%	-$101K	﹤0.01%	449
2023 Q3	$698K	Sell	116,300 -4,001	-3%	-$41.1K	﹤0.01%	437
2023 Q2	$1.47M	Sell	120,301 -6,481	-5%	-$82.7K	0.01%	429
2023 Q1	$1.82M	Sell	126,782 -4,738	-4%	-$89K	0.02%	358
2022 Q4	$1.97M	Sell	131,520 -9,878	-7%	-$284K	0.02%	318
2022 Q3	$5.49M	Sell	141,398 -9,190	-6%	-$528K	0.06%	256
2022 Q2	$11.5M	Hold	150,588	–	–	0.13%	196
2022 Q1	$5.57M	Buy	+150,588	New	+$9.05M	0.06%	277

Alyeska Investment Group's MDVL Position: Q1 2024 in Review

Alyeska Investment Group sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q1 2024, closing a stake of 87,618 shares — an estimated $393K sold.

Alyeska Investment Group first reported a position in MDVL in Q1 2022 and held it in 8 quarters. The position peaked at $11.5M in Q2 2022. 1 fund tracked by Wall St. Rank holds MDVL as of Q1 2024.

Alyeska Investment Group reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Alyeska Investment Group sold 87,618 MedAvail Holdings, Inc. Common Stock shares in Q1 2024, an estimated $393K.
Alyeska Investment Group first reported a position in MedAvail Holdings, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
Alyeska Investment Group's MedAvail Holdings, Inc. Common Stock position peaked at $11.5M in Q2 2022.
1 fund tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q1 2024.

Based on Alyeska Investment Group's 13F filing for Q1 2024, filed 15 May 2024.